| Literature DB >> 31540182 |
Jenny Elomaa1, Laura Gallegos2, Frank A Gomez3.
Abstract
This paper describes the development and application of microfluidic cord-based analytical devices (µCADs) in two enzyme-linked immunosorbent assays (ELISAs) and glucose assay. In this study, biotinylated goat anti-mouse immunoglobulin (IgG) antibody, rabbit IgG antibody, and glucose are quantitatively detected. In the ELISA systems, the antibody is spotted on the cord at the detection site and a series of washes, followed by streptavidin-alkaline phosphatase (Strep-ALP) or alkaline phosphatase (ALP)-conjugated secondary antibody and colorimetric substrate, completing the experiment. The devices are subsequently scanned and analyzed yielding a correlation between inverse yellow or inverse blue intensity and antibody concentration. For the first ELISA, a linear range of detection was observed at lower concentrations (2.50 × 10-4-1.75 × 10-3 mg/mL) of Strep-ALP with saturation of the enzyme achieved at higher concentrations (>2.50 × 10-4). For the second ELISA, the L50 was demonstrated to be 167.6 fmol/zone. The glucose assay consisted of spotting increasing concentrations of glucose on the analysis sites and transporting, via capillary action, a solution containing glucose oxidase (GOx), horseradish peroxidase (HRP), and potassium iodide (KI) to the detection sites realizing a yellow-brown color indicating oxidation of iodide to iodine. The device was then dried, scanned, and analyzed to show the correlation between yellow inverse intensity and glucose. Glucose in artificial urine showed good correlation using the devices.Entities:
Keywords: enzyme-linked immunosorbent assay; microfluidics; microfluidics cord-based analytical device; point-of-care diagnostic device
Year: 2019 PMID: 31540182 PMCID: PMC6780352 DOI: 10.3390/mi10090614
Source DB: PubMed Journal: Micromachines (Basel) ISSN: 2072-666X Impact factor: 2.891
Figure 1Schematic of μCAD for the detection of (A) biotinylated goat anti-mouse IgG, (B) rabbit IgG antibodies, and (C) glucose.
Figure 2Images of increasing concentrations of (A) Strep-ALP: (a) 2.50 × 10−4 mg/mL (b) 3.75 × 10−4 mg/mL, (c) 6.25 × 10−4 mg/mL, (d) 1.00 × 10−3 mg/mL, (e) 1.25 × 10−3 mg/mL, (f) 1.50 × 10−3 mg/mL, (g) 1.75 × 10−3 mg/mL, (h) 2.00 × 10−3 mg/mL, (i) 3.00 × 10−3 mg/mL, (j) 4.00 × 10−3 mg/mL, and (k) 5.00 × 10−3 mg/mL. (B) Inverse yellow mean value intensities as a function of Strep-ALP concentration. Insert is Strep-ALP concentrations ranging from 2.50 × 10−4–1.75 × 10−3 mg/mL. Data are presented as the average ± SD from three independent measurements. The error bars reflect the standard deviations from the average values. (C) Images of increasing rabbit IgG antigen concentrations: (a) 0 fmol/zone, (b) 0.7 fmol/zone, (c) 6.7 fmol/zone, (d) 67 fmol/zone, (e) 670 fmol/zone, (f) 6700 fmol/zone, and (g) 67000 fmol/zone. (D) The sigmoidal curve of corrected inverse blue Intensity as a function of rabbit IgG in fmol/zone (L50 = 167.6 fmol/zone). Data are presented as the average ± SD from three independent measurements. The error bars reflect the standard deviations from the average values.
Figure 3(A) Images of increasing concentrations of glucose: (a) 0.00 mM, (b) 0.50 mM, (c) 1.00 mM, (d) 3.00 mM, (e) 4.50 mM, (f) 6.50 mM, (g) 10.0 mM, (h) 12.5 mM, (i) 15.0 mM. (B) Corrected average inverse yellow intensities as a function of glucose concentration for the µCAD. Data are presented as the average ± SD from three independent measurements. The error bars reflect the standard deviations from the average values.
Comparison of known glucose concentrations to glucose concentrations detected by analysis, with percent difference.
| Known Glucose Concentration (mM) | Detected Concentration (mM) | Percent Difference |
|---|---|---|
| 0.5 | 0.46 ± 0.05 | 9.4 |
| 1.0 | 0.92 ± 0.08 | 8.3 |
| 4.5 | 4.53 ± 0.03 | 0.7 |